BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tee KB, Ibrahim L, Hashim NM, Saiman MZ, Zakaria ZH, Huri HZ. Pharmacokinetic-Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes. Pharmaceutics 2022;14:1268. [PMID: 35745841 DOI: 10.3390/pharmaceutics14061268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bafiti V, Katsila T. Pharmacometabolomics-Based Translational Biomarkers: How to Navigate the Data Ocean. OMICS: A Journal of Integrative Biology 2022. [DOI: 10.1089/omi.2022.0097] [Reference Citation Analysis]
2 Nodari CH, De Quadros ND, Chiarentin R, Da Silva FP, Morisso FDP, Charão MF, Fleck JD, De Mattos CB, Betti AH, Verza SG. Vortioxetine liposomes as a novel alternative to improve drug stability under stress conditions: toxicity studies and evaluation of antidepressant-like effect. Pharmacol Rep 2022. [PMID: 36076124 DOI: 10.1007/s43440-022-00412-w] [Reference Citation Analysis]
3 Tee KB, Ibrahim L, Hashim NM, Saiman MZ, Zakaria ZH, Huri HZ. Pharmacokinetics and Metabolomic Profiling of Metformin and Andrographis paniculata: A Protocol for a Crossover Randomised Controlled Trial. JCM 2022;11:3931. [DOI: 10.3390/jcm11143931] [Reference Citation Analysis]